Brief: United Therapeutics Corporation Prevails In Patent Litigation Against Liquidia
01/10/2026 24:10
BRIEF-United Therapeutics Corporation Prevails In Patent Litigation Against Liquidia Sept 30 (Reuters) - United Therapeutics Corporation UTHR.O:
UNITED THERAPEUTICS CORPORATION PREVAILS IN PATENT LITIGATION AGAINST LIQUIDIA
Source text: ID:nBw20pThLa
Further company coverage: UTHR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Therapeutics
See all newsBrief: United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization
Brief: United Therapeutics Announces FDA Clearance To Proceed With Summit Clinical Trial For Treprostinil Smi In Ph-Copd
Liquidia surges as United Therapeutics settlement removes key litigation risk (updated)
Brief: United Therapeutics Enters Settlement Agreement With Liquidia To Resolve Litigation - SEC Filing
Liquidia surges after $381 million settlement with United Therapeutics for lung disease drug